Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melmed

Showing results (761-770 of 800) with videos related to

Pageof 80
Sort By:
Alimentary Pharmacology & Therapeutics|November 15, 2022
Crohn's disease shared decision making intervention leads to more patients choosing combination therapy: a cluster randomised controlled trialYaara Zisman-Ilani, Kimberly D Thompson, Lori S Siegel, et al.
Journal of Neurosurgical Anesthesiology|December 9, 2021
Perceptions Regarding the SARS-CoV-2 Pandemic's Impact on Neurocritical Care Delivery: Results From a Global SurveyAbhijit V Lele, Sarah Wahlster, Bhunyawee Alunpipachathai, et al.
Medrxiv : the Preprint Server for Health Sciences|December 15, 2021
The T-cell clonal response to SARS-CoV-2 vaccination in inflammatory bowel disease patients is augmented by anti-TNF therapy and often deficient in antibody-respondersDalin Li, Alexander Xu, Emebet Mengesha, et al.
The Journal of Clinical Endocrinology and Metabolism|April 17, 2008
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statementB M K Biller, A B Grossman, P M Stewart, et al.
The American Journal of Gastroenterology|November 19, 2021
Quality of Care Program Reduces Unplanned Health Care Utilization in Patients With Inflammatory Bowel DiseaseGil Y Melmed, Brant Oliver, Jason K Hou, et al.
Frontiers in Immunology|April 25, 2022
Differences in SARS-CoV-2 Vaccine Response Dynamics Between Class-I- and Class-II-Specific T-Cell Receptors in Inflammatory Bowel DiseaseAlexander M Xu, Dalin Li, Joseph E Ebinger, et al.
Frontiers in Physiology|July 17, 2020
cBIN1 Score (CS) Identifies Ambulatory HFrEF Patients and Predicts Cardiovascular EventsTara C Hitzeman, Yu Xie, Ronit H Zadikany, et al.
JAMA|July 22, 2024
Risankizumab for Ulcerative Colitis: Two Randomized Clinical TrialsEdouard Louis, Stefan Schreiber, Remo Panaccione, et al.
Journal of Parkinson'S Disease|December 24, 2019
The Quebec Parkinson Network: A Researcher-Patient Matching Platform and Multimodal BiorepositoryZiv Gan-Or, Trisha Rao, Etienne Leveille, et al.
Nature Neuroscience|October 25, 2011
Pain sensitivity and vasopressin analgesia are mediated by a gene-sex-environment interactionJeffrey S Mogil, Robert E Sorge, Michael L LaCroix-Fralish, et al.
Pageof 80

Showing results (761-770 of 800) with videos related to

Sort By:
Pageof 80
Alimentary Pharmacology & Therapeutics|November 15, 2022
Crohn's disease shared decision making intervention leads to more patients choosing combination therapy: a cluster randomised controlled trialYaara Zisman-Ilani, Kimberly D Thompson, Lori S Siegel, et al.
Journal of Neurosurgical Anesthesiology|December 9, 2021
Perceptions Regarding the SARS-CoV-2 Pandemic's Impact on Neurocritical Care Delivery: Results From a Global SurveyAbhijit V Lele, Sarah Wahlster, Bhunyawee Alunpipachathai, et al.
Medrxiv : the Preprint Server for Health Sciences|December 15, 2021
The T-cell clonal response to SARS-CoV-2 vaccination in inflammatory bowel disease patients is augmented by anti-TNF therapy and often deficient in antibody-respondersDalin Li, Alexander Xu, Emebet Mengesha, et al.
The Journal of Clinical Endocrinology and Metabolism|April 17, 2008
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statementB M K Biller, A B Grossman, P M Stewart, et al.
The American Journal of Gastroenterology|November 19, 2021
Quality of Care Program Reduces Unplanned Health Care Utilization in Patients With Inflammatory Bowel DiseaseGil Y Melmed, Brant Oliver, Jason K Hou, et al.
Frontiers in Immunology|April 25, 2022
Differences in SARS-CoV-2 Vaccine Response Dynamics Between Class-I- and Class-II-Specific T-Cell Receptors in Inflammatory Bowel DiseaseAlexander M Xu, Dalin Li, Joseph E Ebinger, et al.
Frontiers in Physiology|July 17, 2020
cBIN1 Score (CS) Identifies Ambulatory HFrEF Patients and Predicts Cardiovascular EventsTara C Hitzeman, Yu Xie, Ronit H Zadikany, et al.
JAMA|July 22, 2024
Risankizumab for Ulcerative Colitis: Two Randomized Clinical TrialsEdouard Louis, Stefan Schreiber, Remo Panaccione, et al.
Journal of Parkinson'S Disease|December 24, 2019
The Quebec Parkinson Network: A Researcher-Patient Matching Platform and Multimodal BiorepositoryZiv Gan-Or, Trisha Rao, Etienne Leveille, et al.
Nature Neuroscience|October 25, 2011
Pain sensitivity and vasopressin analgesia are mediated by a gene-sex-environment interactionJeffrey S Mogil, Robert E Sorge, Michael L LaCroix-Fralish, et al.
Pageof 80